Affiliation:
1. Institutes of Biomedical Sciences, Shanxi University, Taiyuan 030006, China
2. Shanxi Provincial Key Laboratory of Medical Molecular Cell Biology, Taiyuan 030006, China
3. Shanxi Provincial Key Laboratory for Prevention and Treatment of Major Infectious Diseases, Taiyuan 030006, China
Abstract
Prior to the COVID-19 pandemic, tuberculosis (TB) was the leading cause of death globally attributable to a single infectious agent, ranking higher than HIV/AIDS. Consequently, TB remains an urgent public health crisis worldwide. Oridonin (7a,20-Epoxy-1a,6b,7,14-tetrahydroxy-Kaur-16-en-15-one Isodonol, C20H28O6, Ori), derived from the Rabdosia Rrubescens plant, is a natural compound that exhibits antioxidant, anti-inflammatory, and antibacterial properties. Our objective was to investigate whether Ori’s antioxidant and antibacterial effects could be effective against the infection Mycobacterium marinum (Mm)-infected cells and zebrafish. We observed that Ori treatment significantly impeded Mm infection in lung epithelial cells, while also suppressing inflammatory response and oxidative stress in Mm-infected macrophages. Further investigation revealed that Ori supplementation inhibited the proliferation of Mm in zebrafish, as well as reducing oxidative stress levels in infected zebrafish. Additionally, Ori promoted the expression of NRF2/HO-1/NQO-1 and activated the AKT/AMPK-α1/GSK-3β signaling pathway, which are both associated with anti-inflammatory and antioxidant effects. In summary, our results demonstrate that Ori exerts inhibitory effects on Mm infection and proliferation in cells and zebrafish, respectively. Additionally, Ori regulates oxidative stress by modulating the NRF2/HO-1/NQO-1 and AKT/AMPK-α1/GSK-3β signaling pathways.
Funder
National Nature Science Foundation of China
China Postdoctoral Science Foundation
Subject
Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,Molecular Biology,Immunology and Allergy
Reference32 articles.
1. Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20–22 April 2021;Suliman;Vaccine,2021
2. Inhibiting the stringent response blocks Mycobacterium tuberculosis entry into quiescence and reduces persistence;Dutta;Sci. Adv.,2019
3. A tale of two global emergencies: Tuberculosis control efforts can learn from the Ebola outbreak;Nathavitharana;Eur. Respir. J.,2015
4. World Health Organization (2018). Latent Tuberculosis Infection: Updated and Consolidated Guidelines for Programmatic Management.
5. Self-clearance of Mycobacterium tuberculosis infection: Implications for lifetime risk and population at-risk of tuberculosis disease;Emery;Proc. Biol. Sci.,2021